Concepedia

Mehrdad Mobasher

MM

30

Publications

3.8K

Citations

22

H-Index

2007

Active since

Affiliations

AbbVie (United States)(Current)

St James's University Hospital

Roche (United Kingdom)

Memorial Sloan Kettering Cancer Center

Peter MacCallum Cancer Centre

Mehrdad Mobasher is an author at AbbVie (United States) specializing in medicine, oncology, and immunotherapy.

Top concepts

Publications per year

2007–2022

30

Publications

30

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

John F. Seymour, Thomas J. Kipps, Barbara Eichhorst et al. · New England Journal of Medicine · 2018 · 881 citations · Full text

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo et al. · New England Journal of Medicine · 2019 · 816 citations

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig et al. · The Lancet Oncology · 2016 · 783 citations · Full text

, , +7

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Arnon P. Kater, John F. Seymour, Peter Hillmen et al. · Journal of Clinical Oncology · 2018 · 294 citations

Survival for Patients With Invasive Cutaneous Melanoma Among Ethnic Groups: The Effects of Socioeconomic Status and Treatment

Jason A. Zell, Pelin Cinar, Mehrdad Mobasher et al. · Journal of Clinical Oncology · 2007 · 176 citations

Rows per page

1–5 of 30